DermOQ Oxygen Lab Completes Purchase of ECHO2 Plus Oxygen Facial Treatment Product Line from Skin Products, Inc.

DermOQ plans to offer the Oxygen Lab line of daily skin care products to ECHO2 Plus customers.

DermOQ Oxygen Lab closed their acquisition of ECHO2 Plus Oxyceuticals oxygen facial treatment product line from Skin Products, Inc. for an undisclosed amount.

"ECHO2 Plus is a 45-minute facial treatment offered at physician's offices, spas, hotels and corporate customers, such as Macy's Blue Mercury. The idea for ECHO2 Plus originated in the 1990's with a respiratory therapist who wanted to develop an oxygenated skincare treatment based on the Hyperbaric oxygen benefits he witnessed while working in the hospital," says Ryan Masa, Vice President of Sales for DermOQ, in a news release.

"We are excited to couple the ECHO2 Plus platform with our unique topical oxygen skin care product lines that are offered to skin care providers and through retail sales channels. ECHO2 Plusis a world-wide brand that has been around for 20 years with over 2,200 US based installations and is distributed globally," adds Dr. Bradley Patt, CEO of DermOQ. 

"DermOQ plans to offer it's Oxygen Lab line of daily skin care products to ECHO2 Plus customers who have been asking for a take-home product that would extend and enhance their oxygen treatment results. We believe that the ECHO Plus fan base will be extremely excited about these products. The hero SKU, "Cell Fuel" is a unique formulation combining molecular oxygen for fueling cell metabolism with active nutrients designed to keep your skin at its most dynamic and alive state."